Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Total Operating Expense | 432.61 | 470.97 | 424.84 | 369.46 |
Other Net | 1.15 | - | 4.80 | 0.04 |
Diluted Weighted Average Shares | 1.65 | 1.65 | 1.65 | 1.65 |
Gain( Loss)on Saleof Assets | 1.20 | 0.01 | -0.78 | 0.00 |
Depreciation/ Amortization | 21.43 | 17.07 | 15.50 | 15.66 |
Operating Income | 220.82 | 111.08 | 87.97 | 70.70 |
Net Income | 183.24 | 87.66 | 67.64 | 51.48 |
Income Availableto Com Excl Extra Ord | 183.24 | 87.66 | 67.64 | 51.48 |
Other Operating Expenses Total | 5.14 | 5.91 | - | 3.80 |
Net Income Before Taxes | 232.88 | 117.84 | 91.68 | 73.17 |
Net Income After Taxes | 183.24 | 87.66 | 67.64 | 51.48 |
Income Availableto Com Incl Extra Ord | 183.24 | 87.66 | 67.64 | 51.48 |
Costof Revenue Total | 241.58 | 208.56 | 184.52 | 162.90 |
Gross Profit | 411.85 | 373.49 | 328.29 | 277.26 |
Interest Inc( Exp) Net- Non- Op Total | 9.71 | 6.75 | -0.31 | 2.43 |
Unusual Expense( Income) | -82.60 | - | - | - |
Diluted Net Income | 183.24 | 87.66 | 67.64 | 51.48 |
DPS- Common Stock Primary Issue | 20.00 | 16.00 | 12.00 | 9.60 |
Provisionfor Income Taxes | 49.64 | 30.18 | 24.04 | 21.69 |
period Type | - | - | - | - |
Net Income Before Extra Items | 183.24 | 87.66 | 67.64 | 51.48 |
Total Revenue | 653.43 | 582.05 | 512.81 | 440.16 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Revenue | 653.43 | 582.05 | 512.81 | 440.16 |
Selling/ General/ Admin Expenses Total | 247.06 | 239.43 | 224.82 | 187.10 |
Diluted Normalized EPS | 70.92 | 53.00 | 41.25 | 31.13 |
Diluted EPS Excluding Extra Ord Items | 110.79 | 53.00 | 40.90 | 31.13 |
Rpg Life Sciences Dividend Rpg Life Sciences Bonus Rpg Life Sciences News Rpg Life Sciences AGM Rpg Life Sciences Rights Rpg Life Sciences Splits Rpg Life Sciences Board Meetings Rpg Life Sciences Key Metrics Rpg Life Sciences Shareholdings Rpg Life Sciences Balance Sheet Rpg Life Sciences Cashflow Rpg Life Sciences Q1 Results Rpg Life Sciences Q2 Results Rpg Life Sciences Q3 Results Rpg Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks